Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCollegium Pharmaceutical, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | $1.52 | $1.65 | $1.57 |
| Q2 2025 | 1 | $1.62 | $1.70 | $1.66 |
| Q3 2025 | 1 | $1.73 | $1.82 | $1.78 |
| Q4 2025 | 1 | $1.84 | $1.94 | $1.89 |
| Q1 2026 | 1 | $1.68 | $1.78 | $1.74 |
| Q2 2026 | 1 | $1.72 | $1.81 | $1.77 |
| Q3 2026 | 1 | $1.76 | $1.86 | $1.82 |
| Q4 2026 | 1 | $1.79 | $1.88 | $1.84 |
Collegium Pharmaceutical, Inc. Earnings Date And Information
Collegium Pharmaceutical, Inc. last posted its earnings results on Thursday, February 27th, 2025. The company reported $1.77 earnings per share for the quarter, topping analysts' consensus estimates of $1.54 by $0.23. The company had revenue of 181.95 M for the quarter and had revenue of 631.45 M for the year. Collegium Pharmaceutical, Inc. has generated $2 earnings per share over the last year ($1.71 diluted earnings per share) and currently has a price-to-earnings ratio of 13.74. Collegium Pharmaceutical, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based on prior year's report dates.
Collegium Pharmaceutical, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/27/2025 | Q4 2024 | $1.54 | $0.39 | -1.15 | $179.75 M | $181.95 M |
| 11/07/2024 | Q3 2024 | $1.66 | $0.33 | -1.33 | $155.65 M | $159.30 M |
| 08/08/2024 | Q2 2024 | $1.56 | $0.60 | -0.96 | $143.94 M | $145.28 M |
| 05/09/2024 | Q1 2024 | $1.49 | $0.86 | -0.63 | N/A | $144.92 M |
| 02/22/2024 | Q4 2023 | $1.33 | $0.99 | -0.34 | $147.86 M | $149.75 M |
| 11/07/2023 | Q3 2023 | $1.24 | $0.61 | -0.63 | $137.27 M | $136.71 M |
| 08/03/2023 | Q2 2023 | $1.22 | $0.38 | -0.84 | $138.46 M | $135.55 M |
| 05/04/2023 | Q1 2023 | $1.32 | -$0.51 | -1.83 | N/A | $144.77 M |
| 02/23/2023 | Q4 2022 | $1.03 | -$0.21 | -1.24 | N/A | $129.62 M |
| 11/03/2022 | Q3 2022 | $1.22 | $0.01 | -1.21 | $124.38 M | $127.01 M |
| 08/04/2022 | Q2 2022 | $1.31 | -$0.15 | -1.46 | $121.13 M | $123.55 M |
| 05/10/2022 | Q1 2022 | $0.97 | -$0.39 | -1.36 | N/A | $83.75 M |
| 02/24/2022 | Q4 2021 | $1.04 | -$0.73 | -1.77 | N/A | $27.36 M |
| 11/04/2021 | Q3 2021 | $0.95 | $0.23 | -0.72 | $85.06 M | $78.84 M |
| 08/05/2021 | Q2 2021 | $0.34 | $2.06 | 1.72 | $84.61 M | $82.94 M |
| 05/06/2021 | Q1 2021 | $0.42 | $0.45 | 0.03 | N/A | $87.72 M |
| 02/25/2021 | Q4 2020 | $0.39 | $0.20 | -0.19 | N/A | $76.27 M |
| 11/05/2020 | Q3 2020 | $0.41 | $0.33 | -0.08 | $77.45 M | $79.18 M |
| 08/05/2020 | Q2 2020 | $0.31 | $0.23 | -0.08 | $74.42 M | $78.06 M |
| 05/07/2020 | Q1 2020 | $0.41 | $0.01 | -0.4 | N/A | $76.51 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Collegium Pharmaceutical, Inc. Earnings: FAQ's
Collegium Pharmaceutical, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based offlast year's report dates.
In the previous quarter, Collegium Pharmaceutical, Inc. (:COLL) reported $1.77 earnings per share (EPS) to beat the analysts' consensus estimate of $1.54 by $0.23.
The conference call for Collegium Pharmaceutical, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Collegium Pharmaceutical, Inc.'s latest earnings report can be read online.
Collegium Pharmaceutical, Inc. (:COLL) has a recorded annual revenue of $631.45 M.
Collegium Pharmaceutical, Inc. (:COLL) has a recorded net income of $69.19 M.Collegium Pharmaceutical, Inc. has generated $2.14 earnings per share over the last four quarters.
Collegium Pharmaceutical, Inc. (:COLL) has a price-to-earnings ratio of 13.74 and price/earnings-to-growth ratio is -0.64.